Weifa

From Wikipedia, the free encyclopedia

Weifa ASA
Company typeAllmennaksjeselskap
OSE: WEIFA
IndustryPharmaceutical
Founded1940
HeadquartersOslo, Norway
Revenue500mill NOK (2012)
Number of employees
99
Websitewww.weifa.no

Weifa[1] is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø.

Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards.

Weifa was founded by pharmacist Olaf Weider in 1940.[2]

Therapeutic areas

Weifa focuses on three therapeutic areas:

  1. Pain management
  2. Diabetes management
  3. Food supplements

Products

Active ingredients

Development

With a total of over 99 employees, Weifa is today generating an annual turnover of approximately €40 million (35% of the turnover is achieved internationally). Weifa bases its development on 3 criteria:

  1. International expansion
  2. Expertise in pharmaceuticals and fine chemicals
  3. Partnership agreements

Norway

Export

References

Related Articles

Wikiwand AI